Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

Is there a possible survival benefit to increasing hemoglobin levels with epoetin alfa during chemotherapy?AAPRO, M; BAJETTA, E; FREUND, M et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 20-28, issn 1359-6349, 9 p.Conference Paper

Epoetin alfa has potential efficacy in central nervous system disordersCERAMI, A; BRINES, M; CERAMI, C et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 29-35, issn 1359-6349, 7 p.Conference Paper

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinomaABBREDERIS, Kathrin; BASSERMANN, Florian; SCHUHMACHER, Christoph et al.The Annals of thoracic surgery. 2006, Vol 82, Num 1, pp 293-297, issn 0003-4975, 5 p.Article

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapySCHOUWINK, J. H; CODRINGTON, H; SLEEBOOM, H. P et al.European journal of cancer (1990). 2008, Vol 44, Num 6, pp 819-829, issn 0959-8049, 11 p.Article

Is there a place for epoetin alfa in managing anemia during critical illness?GIVENS, Marlea; LAPOINTE, Marc.Clinical therapeutics. 2004, Vol 26, Num 6, pp 819-829, issn 0149-2918, 11 p.Article

Erythroblastopénies sous époétine (suite) = Red cell aplasie under epoetin alfa (continuation)La Revue Prescrire. 2003, Vol 23, Num 236, issn 0247-7750, p. 111Article

Clinical guidelines for the treatment of cancer-related anemiaKOELLER, J. M.Pharmacotherapy. 1998, Vol 18, Num 1, pp 156-169, issn 0277-0008Article

Optimizing the use of erythropoietic agents: pharmacokinetic and pharmacodynamic considerationsMACDOUGALL, Iain C.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 66-70, issn 0931-0509, SUP5Conference Paper

Alfa-epoietin and anaemia in gynaecological cancerDI COCCO, Barbara; SALESI, Nello; FABI, Alessandra et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1287-1292, issn 0250-7005, 6 p.Article

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patientsPUGLISI, Fabio; DEROMA, Laura; BECCAGLIA, Patrizia et al.Critical reviews in oncology/hematology. 2009, Vol 69, Num 2, pp 175-182, issn 1040-8428, 8 p.Article

Utilisation review of epoetin alfa in cancer patients at a cancer centre in SingaporeCHAN, A; LIM, L. L. C; TAO, M et al.Singapore medical journal. 2009, Vol 50, Num 4, pp 365-370, issn 0037-5675, 6 p.Article

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart diseasePARFREY, Patrick S; FOLEY, Robert N; WITTREICH, Barbara H et al.Journal of the American Society of Nephrology. 2005, Vol 16, Num 7, pp 2180-2189, issn 1046-6673, 10 p.Article

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysisJONES, Michael; IBELS, Lloyd; SCHENKEL, Brad et al.Kidney international. 2004, Vol 65, Num 3, pp 757-767, issn 0085-2538, 11 p.Article

Effect of changing s.c. epoetin alfa administration from thrice weekly to once weekly in hemodialysis patientsTO, Linh L; STONER, Carol P.American journal of health-system pharmacy. 2003, Vol 60, Num 9, pp 931-934, issn 1079-2082, 4 p.Conference Paper

Methods and progress in assessing the quality of life effects of supportive care with erythropoietin therapyYOUNT, Susan; LAI, Jin-Shei; CELLA, David et al.Current opinion in hematology. 2002, Vol 9, Num 3, pp 234-240, issn 1065-6251Article

Epoetin alfa in Cancer patients: Evidence-based GuidelinesTURNER, Robert; ANGLIN, Peter; BURKES, Ronald et al.Journal of pain and symptom management. 2001, Vol 22, Num 5, pp 954-965, issn 0885-3924Article

Management of cancer-related anemia : Epoetin alfa and quality of lifeSOIGNET, Steven.Seminars in hematology. 2000, Vol 37, Num 4, pp 9-13, issn 0037-1963, SUP6Conference Paper

Pharmacokinetics of intraperitoneal epoetin alfa in patients on peritoneal dialysis using an 8-hour dry dwell dosing techniqueTAYLOR, C. A; KOSOROK, M. R; ZIMMERMAN, S. W et al.American journal of kidney diseases. 1999, Vol 34, Num 4, pp 657-662, issn 0272-6386Article

Blood management challenges in orthopedic oncologyJAFFE, K.Orthopedics (Thorofare). 1999, Vol 22, Num 1, pp S161-S163, issn 0147-7447, SUPArticle

The impact of epoetin alfa on quality of life during cancer chemotherapy : A fresh look at an old problemGLASPY, J.Seminars in hematology. 1997, Vol 34, Num 3, pp 20-26, issn 0037-1963, SUP2Article

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndromeKOMROKJI, Rami S; LANCET, Jeffrey E; SWERN, Arlene S et al.Blood. 2012, Vol 120, Num 17, pp 3419-3424, issn 0006-4971, 6 p.Article

Développement clinique de deux biosimilaires: Zarzio^® (filgrastim) et Binocrit^® (époétine α) = Clinical development of two biosimilars: Zarzio^® (filgrastim) and Binocrit^® (epoetin α)LE COTONNEC, J. Y.La Lettre du cancérologue (Boulogne). 2010, Num JUIN, pp 8-13, issn 1165-113X, 6 p., HSArticle

Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck CancerHOSKIN, Peter J; ROBINSON, Martin; SLEVIN, Nicholas et al.Journal of clinical oncology. 2009, Vol 27, Num 34, pp 5751-5756, issn 0732-183X, 6 p.Article

Correction of anemia with epoetin alfa in chronic kidney diseaseSINGH, Ajay K; SZCZECH, Lynda; TANG, Kezhen L et al.The New England journal of medicine. 2006, Vol 355, Num 20, pp 2085-2098, issn 0028-4793, 14 p.Article